Man Group PLC Cytosorbents Corp Transaction History

Man Group PLC

  • $36 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$6.82 - $8.56 $70,477 - $88,459
-10,334 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$7.05 - $12.64 $72,854 - $130,621
10,334 New
10,334 $83,000
Q2 2018

Aug 14, 2018
SELL
$6.9 - $12.35 $94,944 - $169,936
-13,760 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$6.55 - $8.2 $90,128 - $112,831
13,760 New
13,760 $97,000

Others Institutions Holding CTSO

# of Institutions
57
Shares Held
16.7M
Call Options Held
15.4K
Put Options Held
0
View Full List

About Cytosorbents Corp

CTSO Quotes by TradingView
  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $39.2M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email